SCHEMBL23197322

SCHEMBL23197322

CSCCC(=O)OCc1ccc(-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
NPC1 O15118 1/20 0.47
FFAR1 O14842 2/20 0.44
FAAH O00519 1/20 0.44
MGLL Q99685 1/20 0.44
LMNA P02545 2/20 0.44
POLB P06746 1/20 0.44
EPHX1 P07099 1/20 0.44
NAAA Q02083 1/20 0.43
ENPP2 Q13822 1/20 0.42
ABCC4 O15439 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23197318 0.91 ALDH1A1 (0.58) MAPTRAB9AALDH1A1MAPK1L3MBTL1
SCHEMBL23197321 0.85 ALDH1A1 (0.45) MAPTRAB9AALDH1A1MAPK1L3MBTL1
SCHEMBL2704190 0.81 ALDH1A1 (0.54) MAPTRAB9AALDH1A1MAPK1L3MBTL1
SCHEMBL3708328 0.80 TDP1 (0.66) MAPTRAB9ASMN1; SMN2ALDH1A1MAPK1
Hydrochloric Acid SCHEMBL3998153 0.80 IDO1 (0.53) MAPTRAB9ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL21993645 0.80 ALDH1A1 (0.51) MAPTRAB9ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL6667842 0.79 MAPT (0.55) MAPTRAB9ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL27457238 0.79 MGLL (0.53) MAPTRAB9ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL27789016 0.79 MEN1 (0.58) MAPTRAB9ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL26190108 0.78 ALDH1A1 (0.58) MAPTSMN1; SMN2ALDH1A1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339852-A1 DICARBOXYLIC ACID COMPOUNDS, INORGANIC PARTICLES TREATED WITH THE DICARBOXYLIC ACID COMPOUNDS, AND COMPOSITIONS THEREOF 3M INNOVATIVE PROPERTIES COMPANY 2023-10-26 US disclosed
US-20230339852-A1 DICARBOXYLIC ACID COMPOUNDS, INORGANIC PARTICLES TREATED WITH THE DICARBOXYLIC ACID COMPOUNDS, AND COMPOSITIONS THEREOF 3M INNOVATIVE PROPERTIES COMPANY 2023-10-26 US disclosed
WO-2021064530-A1 DICARBOXYLIC ACID COMPOUNDS. INORGANIC PARTICLES TREATED WITH THE DICARBOXYLIC ACID COMPOUNDS, AND COMPOSITIONS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339852-A1 DICARBOXYLIC ACID COMPOUNDS, INORGANIC PARTICLES TREATED WITH THE DICARBOXYLIC ACID COMPOUNDS, AND COMPOSITIONS THEREOF F12, RCC1, C9 MAPT 2243/4885RAB9A 2693/4885SMN1; SMN2 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.